- 4-Week # shares sold: 18,000
- 12-Week # shares sold: 18,000
- 24-Week # shares sold: 40,203
Cramer says SolarCity is too hard for him and he's losing patience with Cigna.
With interest rate hikes this year a distinct possibility, the big money managers are springing into action, Cramer says. Here's what to buy.
Impax (IPXL) reported lower-than-anticipated earnings and revenue for the 2016 second quarter and a downbeat forecast before Tuesday's market open.